Douglas W. Roblin, PhD


Senior Research Scientist



PhD, University of Michigan, Ann Arbor, 1984
MA, The University of Chicago, 1976

Douglas W. Roblin joined MAPRI as senior research scientist in July 2017. His primary responsibility is to work with the other MAPRI research scientists and staff to maintain and enhance the research portfolio of health services, intervention, and epidemiology projects. His areas of interest include patient adherence to recommended care, psychosocial stress and cardiometabolic health, health informatics, and social determinants of health. He currently is working on a study to refine a predictive algorithm for acute exacerbations of COPD, a pilot web-based intervention to reduce risk of non-adherence to bisphosphonate therapy among osteoporosis patients, and a large multisite evaluating the effectiveness of individualized fracture risk information to post-DXA patients.
Prior to joining MAPRI, Dr. Roblin was professor of health management and policy in the School of Public Health at Georgia State University. He previously worked for 25 years with Kaiser Permanente (KP), initially as a statistician and then as a health economist with KP’s national program offices in Oakland, California, and more recently as a senior research scientist with KP’s research program in Atlanta.

Research Interests:

Provider workforce, provider practice variation, patient-provider communication, insurance benefit design, access to care, patient adherence to recommended care, psychosocial stress and cardiometabolic health, health informatics, health services research methods, social determinants of health, and design, implementation, and evaluation of pragmatic clinical trials

For a full list of publications, please see Dr. Roblin’s Curriculum Vitae.

  1. Solimeo SL, Nguyen VT, Edmonds SW, Lou Y, Roblin DW, Saag KG, Cram P, Wolinsky FD.  Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.  Osteoporos Int. 2019;30(5):1033-1041.
  2. Fuller CH, Roblin D, Jones J.  Utilizing syndromic surveillance to evaluate the respiratory effects of fine particulate matter. Ann Am Thorac Soc. 2019. EPub ahead of print.
  3. Hall SF, Wright NC, Wolinsky FD, Lou Y, Edmonds S, Roblin D, Jones M, Saag K, Cram P.  The prevalence of overtreatment of osteoporosis: results from the PAADRN trial.  Arch Osteoporos. 2018 28;13(1):103.
  4. Mazor KM, Kamineni A, Roblin DW, Anau J, Robinson BE, Dunlap BS, Firneno C, Gallagher, TH.  Encouraging patients to speak up about problems in cancer care. Journal of Patient Safety. 2018; In press.
  5. Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M.  Agreement between medical records and self-reports: Implications for transgender health research.  Rev Endocr Metab Disord. 2018;19(3):263-269.
  6. Theis KA, Roblin D, Helmick CG, Luo R.  Employment exit and entry among U.S. adults with and without arthritis during the Great Recession. A longitudinal study: 2007–2009, NHIS/MEPS.  Work.  2018;60(2):303-318.
  7. Getahun D, Nash R, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Safer J, Slovis J, Tangpricha V, Goodman M.  Cross-sex hormones and acute cardiovascular events in transgender persons: A Cohort study.  Ann Intern Med.  2018;169(4):205-213.
  8. Becerra-Culqui T, Nash R, Cromwell L, Flanders W, Getahun D, Giammattei S, Lash T, Millman A, Quinn V, Robinson B, Roblin D, Sandberg D, Silverberg M, Tangpricha V, Goodman M.    Mental health of transgender and gender non-conforming youth compared with their peers.  Pediatrics.  2018;141(5):e20173845..
  9. Owen-Smith A, Gerth J, Sineath C, Barzilay J, Becerra-Culqui TA, Getahun D, Giammattei S, Hunkeler E, Lash T, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Sanchez T, Silverberg MJ, Tangpricha V, Valentine C, Winter S, Woodyatt C, Goodman M.  Association between gender confirmation treatments and perceived gender congruence, body satisfaction and mental health among a cohort of transgender individuals.  J Sexual Health.  2018;15(4):591-600.
  10. Roblin DW, Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Jones MP, Wright NC, Saag KG, Cram P. Changes to dietary intake and physical activity following bone densitometry: The PAADRN randomized controlled trial. Arch Osteoporos. 2018; In press.
  11. Theis KA, Roblin D, Helmick CG, Luo R. Prevalence and causes of work disability among working-age U.S. adults, 2011-2013, NHIS. Disabil Health J. 2018;11(1):108-115.
  1. Development and Validation of a Health Insurance Claims-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
    The objectives of this study are 1) to develop an algorithm to identify AECOPD events in health insurance claims databases, and 2) to validate it using physicians’ reviews of information from electronic medical records as the gold standard.
    Site Principal Investigator
  2. Pathways to Care and Health Outcomes Among DSD Patients
    Goal: The goal of this proposal is to develop a longitudinal study of patterns of care and health outcomes among individuals who were diagnosed with disorders of sex development (DSD).
    Funder: National Institute of Child Health & Human Development
    Role: Co-Investigator
  3. Database cohort study to assess the risk of serious angioedema in association with LCZ696 (sacubitril/valsartan; Entresto) use in Black patients with heart failure in the United States
    Goal: This study will provide estimates of the incidence of angioedema among HF patients initiating sacubitril/valsartan and HF patients initiating an angiotensin-converting enzyme inhibitor (ACEI), with a primary focus on Black HF patients. These estimates will quantify the risk of angioedema among HF patients initiating sacubitril/valsartan compared to HF patients initiating an ACEI.
    Funder: Novartis Pharmaceuticals Corp.
    Role: Co-Investigator
  4. Developing a Prescription Opioid Registry across Diverse Health Systems (NIH HEAL Initiative)
    Goal: Building on past research, this project will establish the infrastructure to expand a prescription opioid registry across diverse health systems in the Addiction Research Network. Harmonized electronic health record data elements will be used to examine how changes in opioid use are associated with other patient outcomes, such as emergency department service utilization, benzodiazepine use, and use of other non-opioid medications (e.g., nonsteroidal anti-inflammatory drugs [NSAIDs] and gabapentin), and how this may vary by patient characteristics and across health systems.
    Funder: National Institute on Drug Abuse
    Role: Site Principal Investigator
  1. Podium: A Multi-Modal Intervention for Improving Osteoporosis Treatment Initiation and Adherence.  Health Care Systems Research Network.  Portland, OR.
  2. Poster: Evaluation of a Complex Care Program for High-Cost/High-Need Patients: Interim Analyses and Findings.  AcademyHealth Annual Research Meeting.  Washington, DC.
  3. Poster: Usual Source of Care as a Moderator between Race / Ethnicity and Blood Pressure Control.  AcademyHealth Annual Research Meeting.  Washington, DC.
  4. Poster: Do Nurse Advice Calls Follow Ozone Pollution? Using Syndromic Surveillance to Evaluate Short-Term Respiratory Effects of Ambient Ozone Concentrations in the Washington, DC Metropolitan Area. International Society for Environmental Epidemiology Annual Conference. Utrecht, NL.
  5. Poster: The Contribution of patient, primary care physician, and primary care clinic factors to good bone health.  AcademyHealth Annual Research Meeting, 2018.  Seattle, WA.
  6. Poster: Multi-Modal intervention for improving osteoporosis treatment initiation and adherence.  AcademyHealth Annual Research Meeting, 2018.  Seattle, WA.
  7. Paper: Association of sources and levels of psychosocial stress with incident hypertension among employed adults. Work, Stress, and Health Conference, 2017. Minneapolis, MN.
  8. Paper: Improved osteoporosis self-efficacy improves exercise and dietary intake of calcium and vitamin D. Gerontological Society of America, Annual Research Meeting, 2016. New Orleans, LA.
  9. Poster: Primary care workforce disruption and associated changes in patterns of treatment for common visits in primary care. AcademyHealth Annual Research Meeting, 2016. Boston, MA.
  10. Poster: Orders for diagnostic services and prescribed medications for management of neck and back pain and acute respiratory infections in primary care: Does type of provider matter? AcademyHealth Annual Research Meeting, 2016. Boston, MA.
  11. Poster: A Novel method for estimating transgender status using EMR data. AcademyHealth Annual Research Meeting, 2015. Minneapolis, MN.